Lipa Medix Incorporated in partnership with Metro Radlinks Network Incorporated opened Lipa Medix Cancer Center (LMCCC), the first cancer center in Lipa City, Batangas last October 2017. It is the first in the Southern Tagalog Region to utilize Tomotherapy for radiation treatment.
Tomotherapy is the first complete IGRT (Image-Guided Radiation Therapy) / IMRT (Intensity-Modulated Radiation Therapy) solution. It combines integrated CT Imaging for exceptional treatment accuracy with a first-of-its-kind helical treatment delivery platform that uses patented beam-shaping technology to precisely target tumors while minimizing the impact on surrounding healthy tissues.
According to LMCCC Medical Director Dr. Nestor L. Atienza, many years ago, they felt the need to build the Cancer Center due to the rising number of cancer patients in the Southern Tagalog Region. LMCCC offers radiation treatment to qualified indigents with active Philhealth membership a No-Balance-Billing package. Qualified indigent Philhealth members can get radiation therapy from LMCCC using only their Philhealth.
LMCCC offers multi-modality treatment such as surgeries, radiation therapy, chemotherapy, hormonal therapy, supportive therapy, cancer patient rehabilitation, and more so patients do not have to go to other facilities to seek related services. LMCCC is a One-Stop-Shop for cancer management.
Ms. Bernadette De Vera, a breast cancer patient from Sariaya, Quezon, shared that it’s more convenient nowadays to have her radiation treatment since it’s just 2 hours away from her hometown. She also rented a dorm dedicated to Lipa Medix’s patients inside the hospital premises to save money and time. It also ensures the safety of her family, especially that it’s still pandemic.
“Ang sabi po ni Doktora sa akin last check up ay okay naman po ang akin progress. Yung mga cancer cells ko ay unti unti nang nawawala. Isa sa advantage dito eh maganda yung mga machines na ginagamit nila dito at yung paggaling mo ang iniisip nila.
Ms. Bernadette De Vera | Breast Cancer Patient
LMCCC also takes careful measures to help the community prevent the spread of the COVID19 Virus and to make their patients safe. All Cancer Center staff already got their second dose of the COVID19 Vaccine. They also require all the staff and patients to have their COVID19 Testing every two weeks. LMCCC is a standalone facility within the hospital compound so cancer patients do not mix with regular hospital patients.